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Z yxin  is  a  co m p o n e n t o f a d h e s io n  p la q u e s  th a t  h a s  
b e e n  su g g e s te d  to  p e r fo rm  re g u la to ry  fu n c tio n s  a t  th e se  
sp e c ia liz e d  re g io n s  o f th e  p la sm a  m e m b ra n e . H ere  w e 
d e sc r ib e  th e  iso la tio n  a n d  c h a ra c te r iz a tio n  of cDNAs 
en c o d in g  h u m a n  a n d  m o u se  zyxin . B o th  th e  h u m a n  a n d  
m o u se  zyx in  p ro te in s  d isp la y  a  c o llec tio n  o f p ro lin e -r ic h  
se q u e n c e s  a s  w e ll a s  th r e e  co p ies  o f th e  LIM  d o m ain , a 
zinc  f in g e r  d o m a in  fo u n d  in  m a n y  s ig n a lin g  m o lecu les. 
T h e  h u m a n  zy x in  p ro te in  is  c losely  r e la te d  in  se q u en c e  
to  p ro te in s  im p lic a te d  in  b e n ig n  tu m o r ig e n e s is  a n d  s te ­
ro id  r e c e p to r  b in d in g . A n tib o d ie s  r a is e d  a g a in s t h u m a n  
zyx in  re c o g n ize  a n  84-kD a p ro te in  b y  W e ste rn  im m uno- 
b lo t an a ly s is . T h e  p ro te in  is  lo c a lize d  a t  foca l c o n ta c ts  in  
a d h e r e n t  e ry th ro le u k e m ia  cells . By N o r th e rn  an a ly s is , 
w e  show  th a t  zy x in  is  w id e ly  e x p re sse d  in  h u m a n  t is ­
sues. T h e  zy x in  g en e  m a p s  to  h u m a n  ch ro m o so m e 
7q32-q36.
Focal contacts represent specialized regions of the plasma 
membrane where the cell engages in integrin-dependent cell 
adhesion to the extracellular matrix. At these sites, the cell 
establishes a transmembrane connection between elements of 
the extracellular matrix and the actin cytoskeleton. The link­
age of the cytoskeleton to the integrin receptors appears to be 
critical for the ability of integrins to function as true receptors 
that relay information about the extracellular environment to 
the cell interior to affect many aspects of cell behavior includ­
ing cell locomotion and cell proliferation (Zigmond, 1996; Shat- 
til et al., 1994; Clark and Brugge, 1995; Miyamoto et al., 1995). 
The integrin receptors contribute to the regulation of cell func­
tion by affecting the activation states of intracellular signal 
transduction cascades (Hynes, 1992; Miyamoto et al., 1995). 
For example, integrin engagement regulates the tyrosine phos­
phorylation of proteins that are co-localized with the receptors 
at the adhesion plaques (Ferrell and Martin, 1989; Golden et 
al., 1990; Shattil and Brugge, 1991; Guan e ta l ., 1991; Kornberg 
et al., 1991; Schaller et al., 1992). Tyrosine phosphorylation
* T h is  w o r k  w a s  s u p p o r t e d  i n  p a r t  b y  N a t i o n a l  I n s t i t u t e s  o f  H e a l th  
p o s td o c to r a l  t r a i n i n g  g r a n t s  ( to  M . E . H . a n d  S . M . B .) a n d  b y  N a t i o n a l  
I n s t i t u t e s  o f  H e a l t h  G r a n t  H L 4 1 5 5 3  (to  M . C . B .). W o r k  p e r f o r m e d  i n  
t h e  U n iv e r s i t y  o f  U t a h  S e q u e n c in g  F a c i l i t y  a n d  B io te c h n o lo g y  C o re
F a c i l i t y  w a s  s u p p o r t e d  b y  N a t i o n a l  I n s t i t u t e s  o f  H e a l t h  G r a n t  
C A 4 2 0 1 4 . T h e  c o s ts  o f  p u b l i c a t i o n  o f  t h i s  a r t i c l e  w e r e  d e f r a y e d  i n  p a r t  
b y  t h e  p a y m e n t  o f  p a g e  c h a rg e s .  T h is  a r t i c l e  m u s t  t h e r e f o r e  b e  h e r e b y  
m a r k e d  “advertisement” i n  a c c o r d a n c e  w i t h  18  U .S .C . S e c t io n  1 7 3 4  
s o le ly  to  i n d i c a t e  t h i s  f a c t .
The nucleotide sequence(s) reported in this paper has been submitted 
to the GenBankTM/EBI Data Bank with accession number(s) Y07711 
and X99063 (murine zyxin) and X94991 (human zyxin).
§ C o n t r i b u t e d  e q u a l ly  to  t h i s  w o rk .
** R e c ip ie n t  o f  a  f a c u l ty  r e s e a r c h  a w a r d  f r o m  t h e  A m e r i c a n  C a n c e r  
S o c ie ty . T o  w h o m  c o r r e s p o n d e n c e  s h o u ld  b e  a d d r e s s e d :  D e p t .  o f  B io lo g y , 
2 0 1  S . B io lo g y  B ld g .,  U n iv e r s i t y  o f  U t a h ,  S a l t  L a k e  C i ty ,  U T  8 4 1 1 2 . T e l.: 
8 0 1 -5 8 1 -4 4 8 5 ;  F a x :  8 0 1 -5 8 1 -4 6 6 8 .
events couple components of the focal contact to downstream 
effector molecules that are likely to influence behaviors such as 
cell proliferation (Clark and Brugge, 1995; Miyamoto et al., 
1995). Cytoskeletal elements that are co-localized with integrin 
receptors may be essential for the docking of signaling proteins 
in association with the adhesive membrane or may participate 
directly in certain responses to integrin occupancy, such as 
membrane protrusion and cell spreading.
one protein that may function in both a signaling and an 
architectural capacity in conjunction with the actin cytoskele­
ton is zyxin (Crawford and Beckerle, 1991; Sadler et al., 1992). 
Zyxin is a low abundance phosphoprotein that is concentrated 
at adhesion plaques and along the actin filament bundles near 
where they insert at the adhesion plaques (Crawford and Beck­
erle, 1991). Zyxin has the molecular features of an intracellular 
signal transducer (Sadler et al., 1992). The protein exhibits a 
striking proline-rich sequence that has been shown to associate 
with SH3 domains that are found in a number of protein 
components of signal transduction pathways. For example, 
zyxin interacts with the human proto-oncogene product Vav, 
an SH3 protein that is required for antigen-dependent signal­
ing in T- and B-cells (Hobert et al., 1996). The proline-rich 
sequences in zyxin are also related to sequences in the ActA 
protein of the intracellular bacterial pathogen Listeria mono­
cytogenes that play a role in coordinated actin assembly at the 
surface of the bacterium (Lasa et al., 1995; Pistor et al., 1995.)
In addition to the proline-rich region, zyxin displays three 
copies of a cysteine- and histidine-rich motif called the LIM 
motif, which is found in a number of proteins involved in the 
regulation of cell proliferation and differentiation (Sadler et al., 
1992; Schmeichel and Beckerle, 1994). The LIM motif has been 
shown to mediate specific protein-protein interactions 
(Schmeichel and Beckerle, 1994; Wu and Gill, 1994; Feuerstein 
et al., 1994). One of the LIM domains in zyxin interacts with 
members of the cysteine-rich protein family that have been 
implicated in myogenic potentiation (Sadler et al., 1992; 
Schmeichel and Beckerle, 1994; Arber et al., 1994). The dem­
onstration that zyxin displays a tandem array of domains that 
mediate specific protein-protein interactions has led to the 
suggestion that zyxin may function as a scaffold for the assem­
bly of multimeric complexes (Schmeichel and Beckerle, 1994). 
These protein assemblages could mediate integrin-dependent 
signaling events that lead to cell differentiation or modulation 
of cytoarchitecture.
Thus far, zyxin has only been characterized in avian cells 
(Crawford and Beckerle, 1991; Crawford et al., 1992; Sadler et 
al., 1992). To identify sequences in zyxin that are central to its 
function and to develop materials to facilitate the study of 
zyxin in mammals, we have initiated an effort to identify and 
characterize human zyxin. Here we report the sequence, ex­
pression pattern, subcellular distribution, and chromosomal 
map position corresponding to human zyxin.




























M A T E R IA L S  A N D  M E T H O D S
Isolation of Human and Mouse Zyxin cDNAs— A  h u m a n  u m b i l ic a l  
v e i n  e n d o t h e l i a l  c e ll  c D N A  (V II-9 1 -5 )  l i b r a r y  c lo n e d  in t o  t h e  .E coR I s i t e  
o f  A g t1 1  w a s  o b ta in e d  f r o m  E . S a d le r  ( W a s h in g to n  U n iv e r s i t y ,  S t.  
L o u is ,  M O ). T h e  l i b r a r y  w a s  s c r e e n e d  w i t h  a  c h i c k e n  z y x in  c D N A  p r o b e  
( S a d le r  et al., 1 9 9 2 )  b y  s t a n d a r d  p r o c e d u r e s .  B r ie f ly ,  a  c h i c k e n  z y x in  
c D N A  f r a g m e n t  c o r r e s p o n d in g  to  n u c l e o t id e s  1 1 3 3 - 1 7 1 8  w a s  la b e le d  
w i t h  32P  u s in g  t h e  P r im e  I t  I I  l a b e l i n g  k i t  ( S t r a t a g e n e ,  L a  J o l l a ,  C A ). 
H y b r id iz a t i o n  w a s  p e r f o r m e d  o v e r n i g h t  a t  5 0  °C i n  5 x  S S P E ,  5 x  
D e n h a r d t ’s  s o lu t io n ,  0 .5 %  (w /v ) S D S , a n d  2 5 0  x g /m l  y e a s t  tR N A  (B o e h -  
r i n g e r  M a n n h e im ) .  F o l lo w in g  h y b r id i z a t io n ,  t h e  f i l t e r s  w e r e  w a s h e d  
tw ic e  a t  r o o m  t e m p e r a t u r e  f o r  1 0  m i n  e a c h  w i t h  2 x  S S P E  a n d  0 .1 %  
(w /v ) S D S  a n d  o n c e  a t  6 0  °C f o r  15  m i n  w i t h  1 X S S P E  a n d  0 .1 %  (w /v ) 
S D S . P la q u e s  g iv in g  s p e c i f ic  s ig n a l s  w i t h  t h e  p r o b e  w e r e  i s o l a t e d  b y  
f o u r  r o u n d s  o f  p u r i f i c a t i o n .  T h e  s iz e s  o f  t h e  i n s e r t s  w e r e  d e t e r m i n e d  b y  
P C R 1 u s in g  A g t1 1  p h a g e  a r m  p r im e r s  a n d  p u r i f i e d  p la q u e s  f r o m  t h e  
f o u r th - r o u n d  s c r e e n  a s  t e m p la t e s .  T h e  p h a g e  i s o l a t e s  c a r r y i n g  la r g e  
i n s e r t s  w e r e  a m p l i f i e d ,  a n d  t h e  i n s e r t  D N A  f r a g m e n t s  w e r e  i s o l a t e d  
a n d  s u b c lo n e d  in t o  t h e  E c o R I  s i t e  o f  t h e  p B lu e s c r ip t  K S -  v e c to r .
T w o  m e th o d s  w e r e  u s e d  to  i s o l a t e  c D N A s  t h a t  in c lu d e d  s e q u e n c e  
c o r r e s p o n d in g  to  t h e  c o m p le te  5 ' - u n t r a n s l a t e d  r e g i o n  o f  z y x in  m R N A . 
I n  t h e  f i r s t  m e th o d ,  p o ly  (A )+ R N A s  p r e p a r e d  f r o m  H E L  c e l ls  a n d  
p u r i f i e d  o n  o lig o (d T )  c o lu m n s  (Q IA G E N  In c . ,  C h a t s w o r th ,  C A ) w e r e  
r e v e r s e - t r a n s c r i b e d  a n d  a m p l i f i e d  u s i n g  t h e  M a r a t h o n  c D N A  a m p l i f i ­
c a t i o n  k i t  ( C L O N T E C H , P a lo  A lto ,  C A ). c D N A  f r a g m e n t s  w e r e  g e n e r ­
a t e d  b y 5 ' - r a p i d  a m p l i f i c a t i o n  o f  c D N A  e n d s ,  s u b c lo n e d  in t o  p B lu e s c r ip t  
K S - , a n d  s e q u e n c e d .  I n  t h e  s e c o n d  m e th o d ,  a  32P - la b e le d  5 '- p r o b e  
p r e p a r e d  f r o m  t h e  h Z y x -2 0  ( w h e r e  “h ” is  h u m a n )  c lo n e  w a s  u s e d  to  
r e s c r e e n  t h e  o r ig i n a l  h u m a n  u m b i l i c a l  v e i n  e n d o t h e l i a l  c e ll  c D N A  l i ­
b r a r y  a s  w e l l  a s  tw o  o t h e r  h u m a n  e n d o t h e l i a l  c e ll  c D N A  l i b r a r i e s  t h a t  
w e r e  k in d l y  p r o v id e d  b y  E . S a d le r .  A  t o t a l  o f  12  c lo n e s  t h a t  w e re  
e x p e c te d  to  c o r r e s p o n d  to  t h e  5 ' - u n t r a n s l a t e d  r e g io n  o f  h u m a n  z y x in  
m R N A  w e r e  a n a ly z e d ,  b u t  n o  a d d i t i o n a l  m e a n in g f u l  s e q u e n c e  b e y o n d  
w h a t  w a s  a v a i l a b l e  f r o m  a n a ly s i s  o f  h Z y x -2 0  w a s  o b ta in e d .  T h e  c o m ­
p le t e  s e q u e n c e  o fh Z y x - 2 0  c D N A  c a n  b e  f o u n d  i n  t h e  G e n B a n k TM/E M B L  
D a t a  B a n k  u n d e r  a c c e s s io n  n u m b e r  X 9 4 9 9 1 .
T w o  a p p r o a c h e s  w e r e  u t i l i z e d  to  o b t a in  f u l l - l e n g t h  m o u s e  c D N A s . 
T h e  i n d e p e n d e n t l y  i s o l a t e d  m o u s e  c D N A  c lo n e s  w e r e  i d e n t i c a l  i n  t h e  
c o d in g  r e g io n s ,  b u t  e x h i b i te d  d i f f e r e n t  a m o u n t s  o f  5 '-  a n d  3 '- u n t r a n s -  
l a t e d  r e g io n s .  F i r s t ,  a  m o u s e  p o s t n a t a l  b r a i n  c a p i l l a r y  c D N A  l i b r a r y  
c lo n e d  i n  v e c to r  A g t1 0  ( S c h n u r c h  a n d  R is a u ,  1 9 9 3 )  w a s  s c r e e n e d  w i t h  a  
h u m a n  z y x in  c D N A  p ro b e .  S e v e r a l  c r o s s - h y b r id iz in g  c lo n e s  w e r e  i s o ­
l a t e d  f r o m  t h i s  l i b r a r y .  O n e  c lo n e  w i t h  a  2 -k b  i n s e r t  w a s  c h a r a c t e r i z e d  
b y  r e s t r i c t i o n  a n a ly s i s  a n d  D N A  s e q u e n c in g .  T h i s  s e q u e n c e  w a s  c o m ­
p le t e  w i t h  r e s p e c t  to  c o d in g  c a p a c i ty .  T h e  s e q u e n c e  o f  t h i s  c D N A  h a s  
b e e n  d e p o s i t e d  i n  t h e  G e n B a n k TM/E M B L  D a t a  B a n k  u n d e r  a c c e s s io n  
n u m b e r  X 9 9 0 6 3 . M o u s e  c D N A s  w e r e  a l s o  i s o l a t e d  f r o m  a n  1 1 .5 -d a y  
m o u s e  e m b ry o  c D N A  l i b r a r y  c lo n e d  in t o  t h e  e x p r e s s io n  v e c to r  A g t11  
(C L O N T E C H ) . T o  s c r e e n  t h i s  l i b r a r y ,  t h e  s e q u e n c e s  e n c o d in g  t h e  L IM  
d o m a in s  w e r e  a m p l i f i e d  f r o m  f i r s t  s t r a n d  m o u s e  f ib r o b l a s t  c D N A  b y  t h e  
p o ly m e r a s e  c h a in  r e a c t io n  u s i n g  d e g e n e r a t e  o l ig o n u c le o t id e  p r im e r s  
t h a t  c o r r e s p o n d e d  to  c o n s e r v e d  r e g io n s  o f  t h e  h u m a n  a n d  c h i c k e n  z y x in  
s e q u e n c e s .  A  c lo n e  w i t h  a  c D N A  i n s e r t  o f  —2 k b  w a s  c h a r a c t e r i z e d  b y  
s e q u e n c e  a n a ly s i s .  T h i s  c D N A  c o n t a in e d  t h e  m a jo r i t y  o f  t h e  c o d in g  
s e q u e n c e  a s  w e l l  a s  a n  e x t e n s iv e  3 ' - u n t r a n s l a t e d  r e g i o n  w i t h  a n  p o ly -  
a d e n y la t i o n  s ig n a l .  T h e  r e m a i n i n g  c o d in g  s e q u e n c e  w a s  d e t e r m i n e d  b y  
a n a ly s i s  o f  m o u s e  g e n o m ic  D N A . T h e  r e s u l t i n g  c o m p o s i te  m o u s e  z y x in  
c D N A  s e q u e n c e  h a s  b e e n  d e p o s i t e d  i n  t h e  G e n B a n k TM/E M B L  D a ta  
B a n k  u n d e r  a c c e s s io n  n u m b e r  Y 0 7 7 1 1 .
DNA Sequencing and Analysis— T h e  s e q u e n c e s  o f  h u m a n  a n d  m o u s e  
zy x in  c D N A s  w e r e  d e t e r m i n e d  f r o m  b o th  s t r a n d s  b y  t h e  m e th o d  o f  
d id e o x y n u c le o t id e  c h a in  t e r m i n a t i o n  s e q u e n c i n g  o f  p o ly m e r a s e  c h a in  
r e a c t io n  p r o d u c t s  (L ife  T e c h n o lo g ie s ,  In c .)  o r  b y  a  m o d i f ic a t io n  o f  t h e  
d id e o x y  c h a in  t e r m i n a t i o n  m e th o d  ( S c h u u r m a n  a n d  K e u le n ,  1 9 9 1 ). 
S o m e  a r e a s  w e r e  a l s o  a n a ly z e d  u s i n g  a u t o m a t e d  s e q u e n c i n g  te c h n o lo g y  
o n  a  M o d e l 3 7 3 A  D N A  s e q u e n c e r  ( A p p lie d  B io s y s te m s ,  I n c . ,  F o s t e r  C ity ,  
C A ) S e q u e n c in g  w a s  p e r f o r m e d  w i t h  s t a n d a r d  p r im e r s  a n d  c u s to m -  
m a d e  o l ig o n u c le o t id e  p r im e r s .  O lig o n u c le o t id e s  w e r e  s y n th e s i z e d  u s in g  
a n  A p p lie d  B io s y s te m s  M o d e l 3 8 0 B  D N A  s y n th e s i z e r .  S e q u e n c e  a n a l y ­
s is  w a s  p e r f o r m e d  w i t h  s o f tw a r e  f r o m  t h e  W is c o n s in  G e n e t ic s  C o m ­
p u t e r  G r o u p  ( D e v e r e u x  et al., 1 9 8 4 )  u s i n g  t h e  p r o g r a m  m a n u a l  f o r  t h e  
G C G  p a c k a g e  ( G e n e t i c s  C o m p u t e r  G r o u p ,  1 9 9 4 ) . T h e  p r o g r a m  B e s t f i t  
w a s  u s e d  to  c o m p a r e  t h e  d e r i v e d  a m in o  a c id  s e q u e n c e s  o f  c h i c k e n  a n d  
h u m a n  z y x in . I n  t h i s  a n a ly s i s ,  o p t i m a l  a l i g n m e n t  i s  a c h ie v e d  w h e n  n in e
g a p s  a r e  in t r o d u c e d ;  n o  g a p s  a r e  r e q u i r e d  f o r  a l i g n m e n t  o f  t h e  L IM  
r e g io n s .  T h e  B e s t f i t  a n d  G a p  p r o g r a m s  w e r e  u s e d  to  c o m p a r e  t h e  
h u m a n  a n d  m o u s e  z y x in  s e q u e n c e s .
Southern Blot Analysis— T o ta l  h u m a n  g e n o m ic  D N A  w a s  p u r c h a s e d  
f r o m  P r o m e g a  (M a d is o n , W I) . D N A  s a m p l e s  (1 0  x g  e a c h )  w e r e  d ig e s t e d  
w i t h  BamHI, BglII, EcoRI, E c o  R V , DraI, o r  H in d I I I .  T h e  r e s u l t i n g  D N A  
f r a g m e n t s  w e r e  r e s o lv e d  b y  e le c t r o p h o r e s i s  o n  a  0 .8 %  a g a r o s e  g e l  a n d  
t r a n s f e r r e d  to  H y b o n d - N + n y lo n  m e m b r a n e  a s  d e s c r ib e d  b y  t h e  m a n u ­
f a c t u r e r  ( A m e r s h a m  C o rp .) .  A  32P - la b e le d  c D N A  c o r r e s p o n d in g  to  n u ­
c le o t id e s  1 1 5 3 - 1 7 3 0 ,  t h e  r e g i o n  e n c o d in g  t h e  L IM  d o m a in s ,  w a s  u s e d  a s  
a  p ro b e .  H y b r id iz a t i o n  w a s  c a r r i e d  o u t  o v e r n i g h t  a t  6 5  °C i n  5 x  S S P E ,  
5 X D e n h a r d t ’s  s o lu t io n ,  0 .5 %  (w /v ) S D S , a n d  2 5 0  x g /m l  y e a s t  tR N A . 
T h e  b lo t  w a s  w a s h e d  tw ic e  a t  r o o m  t e m p e r a t u r e  f o r  1 0  m i n  e a c h  i n  a  
s o lu t i o n  c o n t a in i n g  2 X S S P E  a n d  0 .1 %  (w /v ) S D S  a n d  o n c e  a t  6 5  °C  f o r  
15 m i n  i n  1 X S S P E  a n d  0 .1 %  (w /v ) S D S  a n d  s u b je c te d  to  a  f i n a l  h ig h  
s t r i n g e n c y  w a s h  a t  6 5  °C f o r  1 0  m i n  i n 0 . 1  X S S P E  a n d  0 .1 %  (w /v )  S D S .
Northern Blot Analysis— H u m a n  m u l t i p l e  t i s s u e  N o r t h e r n  b lo t s  (c o n ­
t a i n i n g  p o ly  (A )+ R N A  d e r i v e d  f r o m  h e a r t ,  b r a i n ,  p l a c e n ta ,  l u n g ,  l i v e r ,  
s k e l e t a l  m u s c l e ,  k id n e y ,  p a n c r e a s ,  s p le e n ,  t h y m u s ,  p r o s t a t e ,  t e s t i s ,  
o v a ry ,  s m a l l  i n t e s t i n e ,  c o lo n , a n d  b lo o d  le u k o c y te s )  w e r e  p u r c h a s e d  
f r o m  C L O N T E C H . H y b r id iz a t i o n  w a s  c a r r i e d  o u t  o v e r n i g h t  a t  3 7  °C 
u s i n g  32P - la b e le d  h u m a n  z y x in  c D N A  c o d in g  r e g i o n  i n  5 X S S P E ,  1 0  X 
D e n h a r d t ’s  s o lu t io n ,  1 0 0  x g /m l  d e n a t u r e d  s h e a r e d  s a lm o n  s p e r m  D N A  
( S t r a t a g e n e ) ,  5 0 %  f o r m a m id e  (L ife  T e c h n o lo g ie s ,  I n c .) ,  a n d  2%  (w /v ) 
S D S . T h e  b lo t s  w e r e  w a s h e d  f o u r  t i m e s  a t  r o o m  t e m p e r a t u r e  f o r  10  m i n  
e a c h  i n  a  s o lu t i o n  c o n t a in i n g  2 X S S C  a n d  0 .0 5 %  (w /v ) S D S  a n d  tw ic e  
a t  5 0  °C f o r  2 0  m i n  e a c h  i n  0 .1  X S S C  a n d  0 .1 %  (w /v ) S D S . H y b r id iz a ­
t i o n  w i t h  a  32P - la b e le d  p r o b e  e n c o d in g  g ly c e r a ld e h y d e - 3 - p h o s p h a te  d e ­
h y d r o g e n a s e  w a s  a l s o  c a r r i e d  o u t  a s  a  c o n t ro l .  B lo t  s ig n a l s  w e r e  q u a n ­
t i f i e d  b y  P h o s p h o r I m a g e r  a n a ly s i s  u s in g  I m a g e Q u a n t  s o f tw a r e  ( V e r s io n  
3 .2 , M o le c u la r  D y n a m ic s ,  In c .) .
Indirect Immunofluorescence— H E L  c e l ls  w e r e  g r o w n  i n  R P M I  1 6 4 0  
m e d iu m ( L if e  T e c h n o lo g ie s ,  In c .)  s u p p le m e n te d  w i t h  10%  f e t a l  b o v in e  
s e r u m  (H y c lo n e  L a b o r a to r ie s ) .  C o v e r s l i p s  f o r  i n d i r e c t  im m u n o f lu o r e s ­
c e n c e  w i t h  H E L  c e l ls  w e r e  c o a te d  w i t h  1 m g /m l  f i b r o n e c t in  (L ife  T e c h ­
n o lo g ie s ,  In c .)  i n  1 X p h o s p h a te - b u f f e r e d  s a l i n e ,  i n c u b a t e d  a t  4  °C 
o v e r n i g h t ,  r i n s e d  i n  1 X p h o s p h a te - b u f f e r e d  s a l i n e ,  a n d  p la c e d  i n  a  
C o r n in g  6 0 -m m  P e t r i  d is h .  A p p r o x im a te ly  1 0 6 c e l ls  i n  2 m l  o f  m e d iu m  
w e r e  a d d e d  to  e a c h  d i s h  a n d  w e r e  i n c u b a t e d  f o r  4  h  a t  3 7  °C o n  
f i b r o n e c t in - c o a te d  c o v e rs l ip s  w i t h  1 /xM 1 2 - 0 - te t r a d e c a n o y lp h o r b o l -1 3 -  
a c e t a t e  i n  d im e th y l  s u l fo x id e  (o r  d im e th y l  s u l fo x id e  a lo n e ) .  I n d i r e c t  
im m u n o f lu o r e s c e n c e  w a s  p e r f o r m e d  a s  d e s c r ib e d  p r e v i o u s l y  (B e c k e r le ,  
1 9 8 4 )  u s in g  t h e  B 3 8  r a b b i t  p o ly c lo n a l  a n t i - p l a t e l e t  z y x in  a n t ib o d y  a s  
t h e  p r i m a r y  a n t ib o d y  a n d  r h o d a m in e - c o n j u g a te d  g o a t  a n t i - r a b b i t  Ig G  
a s  t h e  s e c o n d a r y  a n t ib o d y .  V is u a l i z a t i o n  w a s  p e r f o r m e d  o n  a  Z e is s  
A x io p h o t  m ic ro s c o p e .  T h e  B 3 8  a n t i - z y x i n  a n t ib o d y  u s e d  i n  t h i s  s t u d y  is  
a  r a b b i t  p o ly c lo n a l  a n t i - p e p t id e  a n t ib o d y  d i r e c te d  a g a i n s t  t h e  h u m a n  
z y x in  a m in o  a c id  s e q u e n c e  K K F G P V V A P K P K ; a n  N - t e r m in a l  c y s te in e  
r e s i d u e  w a s  a d d e d  to  t h e  z y x in  p e p t id e  s e q u e n c e  to  e n a b le  c o u p l in g  o f  
t h e  p e p t id e  to  c a r r i e r  p r o t e in s  p r io r  to  im m u n iz a t i o n .  T h e  h u m a n  z y x in  
p r o t e in  s e q u e n c e  u s e d  f o r  a n t ib o d y  g e n e r a t i o n  w a s  o b ta in e d  b y  d i r e c t  
m ic r o s e q u e n c e  a n a ly s i s  o f  z y x in  i s o l a t e d  f r o m  h u m a n  p l a t e l e t s . 2 T h e  
s p e c i f ic i ty  o f  t h i s  a n t ib o d y  w a s  d e m o n s t r a t e d  b y  W e s t e r n  im m u n o b lo t  
a n a ly s i s  u s in g  p u r i f i e d  z y x in  a n d  w h o le  c e ll  ly s a t e s .
Western Immunoblot Analysis— A  10%  S D S - p o ly a c r y la m id e  g e l  w a s  
r u n  a c c o r d in g  to  t h e  m e th o d  o f  L a e m m li  (1 9 7 0 )  e x c e p t  w i t h  0 .1 3 %  
b is a c r y la m id e .  W e s t e r n  im m u n o b lo t  a n a ly s i s  w a s  p e r f o r m e d  u s i n g  t h e  
B 3 8  a n t ib o d y  a n d  a  p r o c e d u r e  t h a t  h a s  b e e n  d e s c r ib e d  p r e v io u s ly  (B e c k -  
e r l e ,  1 9 8 6 ) . 125I - P r o t e i n  A  fo llo w e d  b y  a u t o r a d i o g r a p h y  w a s  u s e d  a s  t h e  
d e t e c t i o n  m e th o d .  H E L  c e l l  l y s a t e s  w e r e  p r e p a r e d  a s  fo llo w s . A  C o r n in g  
1 0 0 -m m  P e t r i  d i s h  w a s  c o a te d  w i t h  1 m g /m l  f i b r o n e c t in ,  i n c u b a te d  a t
4  °C  o v e r n i g h t ,  a n d  r i n s e d  o n c e  w i t h  p h o s p h a te - b u f f e r e d  s a l i n e .  C e l ls  
w e r e  c o l le c te d  f r o m  a  c o n f lu e n t  1 0 0 -m m  d i s h  a n d  s p u n  i n  a  ta b le - to p  
c e n t r i f u g e  a t  1 5 0 0  r p m  f o r  2 m in .  T h e  c e ll  p e l l e t  w a s  r e s u s p e n d e d  i n  5 
m l  o f  m e d iu m ,  a n d  t h e  c e l ls  w e r e  a d d e d  to  t h e  f i b r o n e c t in - c o a te d  d is h .  
T u m o r - p r o m o t in g  p h o r b o l  e s t e r  (1 2 -O- te t r a d e c a n o y lp h o r b o l - 1 3 - a c e t a te )  
w a s  a d d e d  to  a  f i n a l  c o n c e n t r a t i o n  o f  1 xM , a n d  t h e  c e l ls  w e r e  i n c u b a te d  
a t  3 7  °C  f o r  4  h .  T h e  c e l ls  w e r e  r i n s e d  f o u r  t i m e s  w i t h  1 X p h o s p h a te -  
b u f f e r e d  s a l i n e  a n d  w e r e  h a r v e s t e d  i n  L a e m m li  s a m p l e  b u f f e r  
( L a e m m l i ,  1 9 7 0 ) . T h e  r e s u l t i n g  l y s a t e  w a s  p a s s e d  th r o u g h  a  2 6 -g a u g e  
tu b e r c u l i n  s y r in g e ,  a n d  t h e  s a m p l e  w a s  b o ile d  f o r  5 m i n  i m m e d i a t e l y  
p r io r  to  lo a d in g  o n to  a  1 0 %  S D S - p o ly a c r y la m id e  g e l.
Chromosomal Mapping— T h e  s o m a t ic  c e ll  h y b r id  c lo n e s  e m p lo y e d  fo r  
c h r o m o s o m a l  l o c a l i z a t i o n  h a v e  b e e n  d e s c r i b e d  p r e v io u s ly  (B o y le  et al. , 
1 9 9 2 ; C ro c e  a n d  K o p r o w s k i ,  1 9 7 4 ; L u e r s s e n  et al., 1 9 9 0 ; R o m m e n s  et
1 T h e  a b b r e v i a t i o n s  u s e d  a r e :  P C R , 
k i lo b a s e  p a i r ( s ) ;  b p , b a s e  p a i r ( s ) .
p o ly m e r a s e  c h a in  r e a c t io n ;  k b ,

























C GG CCCGGCCATG GCGGCCCCCCGCCCGTCTCCCGCGATCTCCGTTTCGGTCTCGGCTCCGGCTTTTT ACG CCCC GCA GAAGAAG TT C GGCCCT GTGGTG GC CCCAAAGCCCAAAGTGAA
M A A 0 R 0 S 0 A  I S V S V S A [7]  A F Y A [ p]  Q K K F G [pj  V V A [pj  K [pj  K V N
TCCCTTCCGGCCCGGGGACAGCGAGCCTCCCCCGGCACCCGGGGCCCAGCGCGCACAGATGGGCCGGGTGGGCGAGATTCCCCCGCCGCCCCCGGAAGACTTTCCCCTGCCTCCACCTCC
0 F * 0 G D S E P P P A [ p ^ G A Q R A Q M G R V G E I  jp P P P P| E P F  [p"| L P P P P
F |P P | A [p]  L E E E I F [~P~| S [7]
rrrrT^ TCif^ nATCy^ CACGATGCaGAGGGTGCrCTGGGAGGTCCCTTCCCGCCGCCCCCTCCCCCGATCGAGGAATCATTTCCCCCTGCGCCTCTGGAGGAGGAGATCTTCCCTTCCgC
78 L A G D G D D A E G A L G G A F  | P P P P P P | I  E E S
GCCGCCTCCTCCGGAGGAGGAGGGAGGGCCTGAGGCCCCCATACCGCCCCCACCACAGCCCAGGGAGAAGGTGAGCAGTATTGATTTGGAGATCGACTCTCTGTCCTCACTGCTGGATGA
118 | P P P ~pj  E E E G G [p]  E A [F]  I  |p P P ~p|  Q [F]  R E K V S S I  D L E I  D S L S S L L D D
CATGACCAAGAATGATCCTTTCAAAGCCCGGGTGTCATCTGGATATGTGCCCCCACCAGTGGCCACTCCATTCAGTTCCAAGTCCAGTACCAAGCCTGCAGCCGGGGGCACAGCACCCCT
M T K N D 0 F K A R V S S G Y V  P P P  V A T 0 F S S K S S T K 0 A A G G T A 0  1
GggXSC TT GGAAGTC CCCTTCCAGCTCCCAGCCTCTGCCCCAGGTTCCGGCTCCGGCTCAGAGCCAGACACAGTTCCATGTT CAGCCC CAGCCCCAGCCCAAGCCTCAGGTCCAACTC CA 
j P P | W K S 0 S  S S o [ p] l 0 Q  v [p] a [p] a Q S Q T  Q F H V Q Q [F j Q K [p j Q V Q L H
TGTCCAGTCCCAGACCCAGCCTGTGTCTTTGGCTAACACCCAGCCCCGAGGGCCCCCAGCCTCATCTCCGGCTCCAGCCCCTAAGTTTTCTCCAGTGACTCCTAAGTTTACTCCTGTGGC
V Q S Q T q [ 7 ] v s L A K T q [p] r g  | p p|  A S S 0 A 0 A 0 K  F S [p] V T [7 ] K F T [ p]  V A
TTCCAAGTTCAGTCCT GGAG CCCCAGGTGGAT CTGGGTCACAACCAAATCAAAAAT TGGGGCAC CC CGAA GCTCTTTCTGCT GGCACA GGCTCCCCT CAACCTCCCAGCTTCACCTATGC 
S K F  S 0 S  A 0 G  G S G S Q [p]  » Q K L G H [ p]  E A L S A G T G S [p ] Q f  P P)S F T Y A
CCAGCAGAGGGAGAAGCCCCGAGTGCAGGAGAAGCAGCACCCCGTGCCCCCACCGGCTCAGAACCAAAACCAGGTGCGCTCCCCTGGGGCCCCAGGGCCCCTGACTCTGAAGGAGGTGGA
0 Q _R E K[ p]  R. V Q E K Q H |T) V |p P p| A Q N Q N  Q V  R S [¥ ] G A [_£_] G [¥J L T L K E V  E
GGAGCTGGAGCAGCTGACCCAGCAGCTAATGCAGGACATGGAGCATCCTCAGAGGCAGAATGTGGCTGTCAACGAACTCTGCGGCCGATGCCATCAACCCCTGGCCCGGGCGCAGCCAGC
E L E  Q L T Q Q  L M Q  D M E  H |T ] Q R Q N V  A V N E L ©  G R ©  H Q jT ] L A R A Q |P j A
CGTCCGCGCTCTAGGGCAGCTGTTCCACATCGCCTGCTTCACCTGCCACCAGTGTGCGCAGCAGCTCCAGGGCCAGCAGTTCTACAGTCTGGAGGGGGCGCCGTACrGCGAGGGCTGTTA
V R A L G Q L F  ©  I  A ©  F T ( c)  H Q ( c)  A Q Q L Q G Q Q F Y S L E G A [ p ] Y  ( c)  E G ( c)  Y
CACTGACACCCTGGAGAAGTGTAACACCTGCGGGGAGCCCATCACTGACCGCATGCTGAGGGCCACGGGCAAGGCCTATCACCCGCACTGCTTCACCTGTGTGGTCTGCGCCCGCCCCCT
t d t l e k @ n t (c) g e [p] i t d r m l r a t g k a y  H © F  T (c )  V v ©  A R [p j L
GGAGGGCACCTCCTTCATCGTGGACCAGGCCAACCGGCCCCACTGTGTCCCCGACTACCACAAGCAGTACGCCCCGAGGTGCTCCGTCTGCTCTGAGCCCATCATGCCTGAGCCTGGCCG
E G T S F I V D Q A N R [ p ] H ( c ) v  0 ®  H K Q Y a H R © S v © S  E [p]  I m [ p] e [ ¥ ] g R
AGATGAGACTGTGCGAGTGGTCGCCCTGGACAAGAACTTCCACATGAAGTGTTACAAGTGTGAGGACTGCGGGAAGCCCCTGTCGATTGAGGCAGATGACAATGGCTGCTTCCCCCTGGA
D E T V R V V A L D K N F (h)  M K ©  Y K ©  E D ©  G K [p~| L S I E A D D N G C F 0  1
CGGTCACGTGCTCTGTCGGAAGTGCCACACTGCTAGAGCCCAGACCTGAGTGAGGACAGGCCCTCTTCAGACCGCAGTCCATGCCCCATTC?rGGACCACCCACACrGAGACCACCTGCGC I800 





F ig .  1. N u c l e o t i d e  a n d  d e d u c e d  a m i n o  a c i d  s e q u e n c e s  o f  h u m a n  z y x i n  c D N A . N u c le o t id e  n u m b e r s  a r e  i n d i c a t e d  o n  t h e  r i g h t ,  a n d  a m in o  
a c id  n u m b e r s  a r e  i n d i c a t e d  o n  t h e  le f t .  T h e  r e g io n s  o f  t h e  d e d u c e d  a m in o  a c id  s e q u e n c e  t h a t  c o r r e s p o n d  to  t h e  f o u r  e n d o p r o t e o ly t ic  p e p t id e s  
m ic r o s e q u e n c e d  f r o m  p u r i f i e d  h u m a n  p l a t e l e t  z y x in  p r o t e i n  a r e  underlined in bold; tw o  underlined a r g i n in e  r e s id u e s  w e r e  n o t  u n a m b ig u o u s ly  
a s s ig n e d  in  t h e  p e p t id e  s e q u e n c e  a n a ly s i s .  T h e  A T G  s t a r t  c o d o n , s to p  c o d o n , a n d  p o l y a d e n y la t i o n  s ig n a l  a r e  underlined. P r o l in e  r e s id u e s  a r e  boxed; 
c y s te in e ,  h i s t i d i n e ,  a n d  a s p a r t i c  a c id  r e s id u e s  t h a t  c o m p r is e  t h e  c o n s e r v e d  m e ta l - b in d in g  r e s id u e s  o f  t h e  L IM  d o m a in  a r e  circled. T h e  n u c l e o t id e  
a n d  d e d u c e d  a m in o  a c id  s e q u e n c e s  h a v e  b e e n  d e p o s i t e d  i n  t h e  G e n B a n k TM/E M B L  D a t a  B a n k  u n d e r  a c c e s s io n  n u m b e r  X 9 4 9 9 1 .
al., 1 9 8 8 ; V o r tk a m p  et al., 1 9 9 1 ) . E c o R I - r e s t r i c t e d  D N A  (1 2  jxg e a c h )  
f ro m  t h e  s o m a t ic  c e l l  h y b r i d  l i n e s  a n d  t h e  c o n t r o l  c e l l  l i n e s  u s e d  in  t h e  
c h r o m o s o m a l  m a p p in g  p a n e l  w a s  f r a c t i o n a t e d  o n  a  0 .8 %  a g a r o s e  g e l, 
t r a n s f e r r e d  to  a  n y lo n  m e m b r a n e ,  a n d  h y b r id i z e d  to  a  32P - la b e le d  
f r a g m e n t  c o r r e s p o n d in g  to  n u c l e o t i d e s  1 1 5 3 - 1 7 3 0  o f  t h e  z y x in  c D N A . 
T h e  h y b r id i z a t io n  p ro to c o l  w a s  e s s e n t i a l l y  e q u i v a l e n t  to  t h a t  d e s c r ib e d  
a b o v e  fo r  S o u t h e r n  a n a ly s i s .  T h e  p r o b e  d e t e c t s  h u m a n - s p e c i f ic  h y b r i d ­
i z a t i o n  o f  a  6 .8 -k b  E c o R I  f r a g m e n t .
F o r  h ig h e r  r e s o lu t io n  a n a ly s i s  o f  t h e  p o s i t i o n  o f  t h e  z y x in  g e n e ,  P C R  
a m p l i f i c a t i o n  w i t h  z y x in - s p e c if ic  p r i m e r s  w a s  u s e d  to  a s s a y  t h e  p r e s ­
e n c e  o f  z y x in  s e q u e n c e s  i n  g e n o m ic  D N A  f r o m  s e v e r a l  h u m a n - r o d e n t  
s o m a t ic  c e l l  l i n e s  t h a t  d i s p l a y  p a r t s  o f  h u m a n  c h r o m o s o m e  7. T h e  P C R  
p r im e r s  (P l,  5 ' -A C T C C A T T C A G T T C C A A G T -3 '; a n d  P r ,  5 '-A C T G - 
G A G A A A A C T T A G G -3 ')  w e r e  d e r i v e d  f ro m  t h e  k n o w n  c D N A  s e q u e n c e  
a n d  g iv e  r i s e  to  a  2 7 0 -b p  a m p l i f i c a t i o n  p r o d u c t  f ro m  t h e  z y x in  g e n e .  
R e a c t io n s  w e r e  p e r f o r m e d  in  a  t o t a l  v o lu m e  o f  5 0  jxl c o n t a in i n g  2 0 0  n g  
o f  g e n o m ic  D N A  t e m p l a t e ,  10  m M  T r i s - H C l ,  p H  9 .0 , 5 0  mM  K C l, 1 .5  mM 
M g C l2, 0 .1 %  T r i to n  X -1 0 0 , 0 .0 2 %  g e l a t i n ,  2 0 0  ^M  e a c h  d N T P ,  1 0 0  n g  o f  
e a c h  p r im e r ,  a n d  1 u n i t  o f  Pfu D N A  p o ly m e r a s e .  T h e  t e m p l a t e  D N A  w a s  
s u b je c te d  to  3 2  c y c le s  o f  a m p l i f i c a t i o n  (1  m i n  a t  9 4  °C , 3 0  s  a t  5 0  °C , a n d  
2 m i n  a t  72  °C ).
R E S U L T S
Isolation an d  Characterization o f  H um an and Mouse Zyxin  
cDNAs—In an effort to identify human zyxin cDNA, a partial 
chicken cDNA that encoded the LIM region of zyxin was used to 
screen a human umbilical vein endothelial cell cDNA library. 
From 750,000 recombinants screened, seven positive plaques 
were isolated and purified. Five of the seven isolates were 
subcloned into the EcoRI site of pBluescript and sequenced. 
Comparison of the nucleotide sequences with the reported 
chicken zyxin sequence suggested that all five isolated cDNAs 
carried inserts that encoded human zyxin. The largest clone 
(hZyx-20) was sequenced in entirety on both strands. The nu­
cleotide and deduced amino acid sequences of human zyxin
derived from cDNA clone hZyx-20 are shown in Fig. 1. The 
human zyxin cDNA is 2166 bp long. This size is very close to 
the transcript size observed by Northern analysis. The nucle­
otide sequence presented in Fig. 1 represents the extent of 
unambiguous zyxin cDNA sequence that we obtained by a 
variety of methods. Additional 5'-cDNA sequences defined ei­
ther by employing a 5'-rapid amplification of cDNA ends stra t­
egy or by exhaustive rescreening of multiple cDNA libraries 
were divergent both in terms of absolute sequence and length 
and are therefore not included in this report. The cDNA se­
quence exhibits a polyadenylation signal (AATAAA) at the 
3 '-end and a potential initiation codon (ATG) beginning at 
nucleotide 11. The nucleotide sequence around this codon (GC- 
CATGG) fits the Kozak consensus for initiation sequences 
(Kozak, 1986). The open reading frame of 1716 bp encodes a 
protein of 572 amino acid residues with a predicted unmodified 
Mr of 61,273. Comparison of the deduced amino acid sequence 
with peptide sequences derived by endoproteolytic cleavage of 
purified human zyxin2 strongly suggested that the cDNA we 
had isolated corresponds to the human zyxin transcript. In 
particular, with the exception of two amino acid residues that 
were ambiguous in the protein sequence analysis, the se­
quences of all four endoproteolytic peptides microsequenced 
were equivalent to regions of the deduced amino acid sequence. 
Since the peptide sequences analyzed (85 residues) arose from 
different parts of the purified zyxin protein, the results 
strongly suggest that the hZyx-20 clone is a bona fide  human 
zyxin cDNA.
The overall molecular architecture and amino acid sequence 
of human zyxin are closely related to those of its avian homo- 
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F ig .  2 . C o m p a r i s o n  o f  t h e  a m i n o  
a c i d  s e q u e n c e s  o f  c h i c k e n  a n d  h u ­
m a n  z y x i n .  A , a  s c h e m a t i c  r e p r e s e n t a ­
t i o n  o f  c h i c k e n  a n d  h u m a n  z y x in  p r o te in s .  
T h e  g lo b a l  a r c h i t e c t u r e  of t h e  p r o t e i n  is  
c o n s e r v e d  i n  t h e  h u m a n  a n d  a v i a n  p r o ­
te in s ;  h o w e v e r ,  t h e  h u m a n  p r o t e i n  e x h i b ­
i t s  a  f e w  s h o r t  s e q u e n c e s  t h a t  a r e  n o t  
f o u n d  in  t h e  a v i a n  p r o t e in .  aa, a m in o  a c ­
id s .  B, a  c o m p a r i s o n  o f  t h e  a m in o  a c id  
s e q u e n c e s  o f  c h i c k e n  a n d  h u m a n  z y x in . 
T h e  p r o t e i n s  d i s p la y  s u b s t a n t i a l  s i m i l a r ­
i ty ,  p a r t i c u l a r l y  i n  t h e  C - t e r m in a l  L IM  
r e g io n . I d e n t i c a l  r e s id u e s  a r e  i n d i c a t e d  b y  
vertical lines. C , a  c o m p a r i s o n  o f  t h e  
a m in o  a c id  s e q u e n c e s  o f  h u m a n  a n d  
m o u s e  z y x in .  I d e n t i c a l  r e s id u e s  a r e  i n d i ­
c a t e d  b y  vertical lines.
Chi ck: 1 MASPGTPGTRMTTTVSINISTPS FY NP QKKFAP WAP KP KVNP FKT GGTSESSQPQ P PGTGAQRAQIGRVGEIPVSVTAEELP LP PPP. .PPGEELSFSS 9 8
I I I I II I I I II I I I I I I I I I I I I I II I I I II I II I I I I I I I I I II I I 
human: 1 .......MAAPRPSPAISVSVSAPAFYAPQKKFGPWAPKP KVNPFRP GDSE....... P PP APGAQRAQMGRVGEIP. PPPPEDFP LP PPPLAGDGDDAEGAL 8 9
99 NCAFPPPPPPFEEPFPPAPDEAFPSPPPPPPPMFDEGPALQIPP....................... GSTGSVEKPLAP.. .. KAHVEISSAPRDPTPPFPSKFTPKP 179
I M I I II I I II I I I I I I I I I I I II III I I  III | || I I II
90 GGAFPPPPPP IEESFPP APLEEEIFPSPPP PP EEEGGPEAPIPPPPQPREKVSSIDLEIDSLSSLLDDMTKNDPFKARVSSGYVPPPVATPFSSKSSTKP 189
180 SGTLSSKPPGLDSTPAPAPWA............................................................APQQRKEPLASVPPPPSLPSQPTAKFTPPPVASSPGSKPGAT 242
I I  I I I I I I I I I I I I I I I I I I
190 AAGGTAPLPPWKSPSSSQPLPQVPAPAQSQTQFHVQPQPQPKPQVQLHVQSQTQPVSLANTQPRGPPASSPAPAPKFSPVTPKFTPVASKFSPGAPGGSG 289
243 VPMAPSNSTRYPTSLQTQFTAPSPSGPLSRPQPPNFTYAQQWERPQVQEKPVPTEKSAAVKDMRRPTADPPKGNSPLTMKEVEELELLTQKLMKDMDHPP 342 I I I i I I I I I I I I I I I II I I I I I I I I I I I I I || | I | | | | | | | | 1
290 SQ. .PNQKLGHPEAL............. SAGTGSPQPP SFTYAQQREKPRVQEKQHPVP PPAQNQNQVRSPGAP___GPLTLKEVEELEQLTQQLM3DMEHPQ 374
343 PVEAATSELCGFCRKPLSRTQPAVRALDCLFHVECFTCFKCEKQLQ GQQFYNVDEKPFCEDCYAGTLEKCSVCKQTITDRMLKATGNSYHPQCFTCVMCH 442 
I I I I I I I I I I I I II I I III j I I I I I I I I I I | I II I I I I I I I I I I I I I I I I II I I I I I I I II 
375 RQNVAVNE LC GRCHQP LA RAQPAVRALGQLFHIACFTCHQCAQQLQGQQFYSLEGAPYCEGCY TDTLEKCNTCGEPITDRMLRATGKAYHPHCFTCWCA 474
443 TPLEGASFIVDQANQPHCVDDYHRKYAPRCSVCSEP1MPEPGKDETVRWALEKNFHMKCYKCEDCGRPLSIEADENGCFPLDGHVLCMKCHTVRAKTAC 5421111 ll M 1111 11 ii Ml 11111111 ii 1111111 11 ii 11111 1111111111; ii I 111 ii 11 1111 ii M 1111 1111 ii i
475 RP LEGT SF IVDQANRPHCVPDY HKQ YAPRCSVCSEPIMPEP GRD ETVRWALDKNFHMKCYKCEDCGKPLSIEADDNGCFP LDGHVLCRK CHTARAQT 5 72
mouse: 1 MAAPRPPPAISVSVSAPAFYAPQKKFAPWAPKPKVNPFRPGDSEPPVAAGAQRAQMGRVGEIPPPPPEDFPLPPPPLIGEGDDSEGALGGAFPPPPPPM 100 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I II I I I I I I I I I I I I I II I I I II II I I I I I I|IIII I III N I I I I I I I I I I I I human: 1 MAAPRPSPAI SVSVSAP AFYAPQKKFGPWAP KP KVNPFRP GDSEP PPAPGAQRAQMGR VGEIPPPPPEDFPLPPPP LAGDGDDAEGALG GAFP PPPPP. 99
101 IEEPFP PAPLEEDIFPSPPPPLEEEGGPEAPTQLP PQPREKVCSIDLEIDSLS S LLDDMTKNDPFKARVSSGYVP PPVATPFVPKPSTKP AP GGTAP LPP 200 
HI I I I I I I I I I I I I I I I I I I I I I I I I I Ml I I I I I I I I I II I I I I I I I I I I II | I I I | M II I I I I I I I II I I I I I I I I I II I I II I I
100 IEESFPPAPLEEEIFPSP PPPP EEEGGPEAPIPPPPQPREKVSSIDLEIDS LS SLLDDMTKNDPFKARVSSGYVP PPVATPFS SKSSTKP AAGGTAP LP P 199
201 WKTPSSSQPPPQ..PQAKPQVQLHVQPQAKP............HVQPQPVSSANTQPRGPLSQAPTPAPKFAPVAPKFTPWSKFSPGAPSGPGPQPNQKMVPP 290
M I I I M I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II I I I I I I I I
200 WKSPSSSQPLPQVPAPAQSQTQFHVQPQPQPKPQVQLHVQSQTQPVSLANTQPRGPPASSPAPAPKFSPVTPKFTPVASKFSPGAPGGSGSQPNQKLGHP 299
291 DAP SSV STGSPQPPSFTYAQQKEKP LVQEKQHPQPPPAQNQNQVRSP GGPGPLTLKEVEELEQLTQQLMQDMEHPQRQSVAVNESCGKCNQP LA RAQ PA V 390 
I I 11 M I II II I I I I III I I I I I II I I II I I II I II I I I I I I I I I I I I I I I I I I I | | | | | | | | | | | | | Mil! || | | || | || 11 ||
300 EALSA. GTGSPQPPSFTYAQQREKPRVQEKQHPVPPPAQNQNQVRSPGAPGPLTLKEVEELEQLTQQLMQDMEHPQRQNVAVNELCGRCHQPLARAQPAV 398
391 RALGQ LFH ITCFTCHQCQQQLQ GQQFY SLEGAP Y CEGCYTDTLEKCNTCGQPITDRMLRATGKAY HPQCFTCWCACP LEGTSFIVDQAN QPHCVPD YHK 4 90 
I I I I I I I I I II II II I I I II IIIIIIII I IIII I I I IIII I I I II II I ! II I I I M I I I I I II I I I II II I I I I I II II I I I I I I I I I IIIIII 
399 RALG2 LFH I ACFTCHQCAQQLQGQQFY SLEGAP YCEGCY TDTLEKCNTCGEP ITDRMLRATGKAYHPHCFTCWCARP LEGTSFI VDQANRPHCVPD YHK 4 98
491 QYAPRCSVCSEPIMPEPGRDETVRWALDKNFHMKCYKCEDCGKPLSIEADDNGCFPLDGHVLCRKCHSARAQT 564 
I I I M II I I I II IIII IIiI I I 11 I IIIIIIIIII I I I IIII I II II I II IIII I II II I II I I II 1 I II I I I
499 QYAPRCSVCSEPIMPEPGRDETVRWALDKNFHMKCYKCEDCGKPLSIEADDNGCFPLDGHVLCRKCHTARAQT 572
similarity to the chicken protein. The predicted unmodified pi 
of human zyxin is 6 .6, a value that is similar to the neutral pi 
predicted from the chicken zyxin sequence. interestingly, as is 
the case for chicken zyxin (Sadler et al., 1992), specific regions 
of the human zyxin protein display substantial position-de­
pendent fluctuations in their predicted isoelectric points. When 
analyzed in intervals of 100  amino acids, we observe acidic 
domains (amino acids 1-99, pi 5.0; amino acids 100-199, pi = 
4.1) and a basic region (amino acids 200-299, pi 12.1) that is 
completely devoid of aspartate and glutamate residues. The 
remaining protein sequence (amino acids 300-572) displays a 
near-neutral predicted pi of 6.9.
Like chicken zyxin, the human zyxin protein features a pro­
line-rich sequence in the N-terminal region of the protein and 
three tandemly arranged LIM domains in the C-terminal re­
gion of the protein. The proline residues of human zyxin are 
boxed in Fig. 1. Both human zyxin and chicken zyxin exhibit a 
high proline content (18%) compared with the 5% found in 
typical eukaryotic proteins (Sadler et al., 1992). The majority 
(86%) of the prolines are found in the N-terminal 350 amino 
acids of human zyxin; the proline content in this region exceeds 
25%. Between amino acids 64 and 137, the proline content is
43%, and numerous arrays of up to six contiguous proline 
residues are observed. The proline-rich region of human zyxin 
is punctuated by the insertion of certain short sequences in­
cluding a 37-amino acid glutamine-rich sequence (amino acids 
211-247) that is not found in its avian counterpart. The overall 
glutamine content of human zyxin is also high, 8% compared 
with 4% in a typical eukaryotic protein. in addition, a serine- 
rich region is observed from amino acids 169 to 291; in this 
area, the serine content is 16% compared with 7% in a typical 
protein. The region of the protein that displays the LIM do­
mains (amino acids 384-565) is the most highly conserved. 
Cysteine and histidine residues that are involved in zinc coor­
dination by the LIM domains are circled in Fig. 1. in this area 
(amino acids 384-565), human zyxin displays 76% identity to 
chicken zyxin. Comparison of the sequences of the three indi­
vidual LIM domains in human and chicken zyxin reveals 62% 
identity for LIM1, 71% identity for LIM2, and 92% identity for 
LIM3. in  LIM3, there are only five amino acid differences 
between the human and chicken sequences, and four of these 
changes are very conservative substitutions (Fig. 2B). Regions 
of striking similarity between the human and chicken zyxin 





























F ig . 3 . N o r t h e r n  b l o t  a n a l y s i s  o f  t h e  d i s t r i b u t i o n  a n d  e x p r e s ­
s i o n  o f  h u m a n  z y x i n  m R N A .  A , N o r t h e r n  b lo t  a n a ly s i s  o f  m R N A  
d e r i v e d  f ro m  v a r i o u s  h u m a n  t i s s u e s .  E a c h  l a n e  c o n t a in s  f r o m  1 to  6  x g  
o f  p o ly  (A )+ R N A : h e a r t ,  5 x g ;  b r a i n ,  1 .5  x g ;  p l a c e n ta ,  1 .5  x g ;  l u n g ,  1 x g ; 
l i v e r ,  2 x g ;  s k e l e t a l  m u s c l e ,  4  x g ;  k id n e y ,  1 x g ;  p a n c r e a s ,  6  x g ;  s p le e n ,  
2 xg ; t h y m u s ,  2 xg ; p r o s t a t e ,  2 xg ; t e s t i s ,  4  xg ; o v a r y ,  3  xg ; s m a l l  
i n t e s t i n e ,  2 .2 5  x g ;  c o lo n , 2 x g ;  a n d  b lo o d  le u k o c y te s ,  2 .7 5  x g .  T h e  b lo t s  
w e r e  h y b r id i z e d  w i t h  a  32P - la b e le d  h u m a n  z y x in  c D N A  p r o b e  t h a t  
c o r r e s p o n d e d  to  t h e  p r o t e in  c o d in g  r e g io n .  T h e  r e l a t i v e  p o s i t i o n  o f  a n  
R N A  s iz e  m a r k e r  i s  i n d i c a t e d  o n  t h e  le f t .  B , q u a n t i t a t i v e  a n a ly s i s  o f  t h e  
r e s u l t s  s h o w n  i n  A. T h e  s ig n a l s  f r o m  t h e  N o r t h e r n  b lo t s  w e r e  q u a n t i f i e d  
b y  P h o s p h o r l m a g e r  a n a ly s i s ,  a n d  v a l u e s  w e r e  n o r m a l iz e d  w i t h  r e s p e c t  
to  t h e  s p e c i f ic  a m o u n t s  ( m ic r o g r a m s )  o f  p o ly  (A )+ R N A  u s e d  f o r  e a c h  
t i s s u e .  m R N A  le v e ls  a r e  e x p r e s s e d  a s  p e r c e n t  o f  t h e  m a x im u m  e x p r e s ­
s io n  d e t e c te d  i n  R N A  s a m p l e s  o b ta in e d  f r o m  l u n g  t i s s u e .
protein partners, including a-actinin, cysteine-rich protein, 
and SH3 proteins (Crawford et al., 1992; Sadler et al., 1992; 
Hobert et al., 1996).
We have also isolated and characterized full-length mouse 
cDNAs. The open reading frame codes for a protein of 564 
amino acids with an unmodified pi of 6.4 (Fig. 2C). Mouse zyxin 
displays the same overall molecular architecture as human and 
chicken zyxin, exhibiting an extensive proline-rich region and 
three tandemly arrayed LIM domains. The mouse protein ex­
hibits 88% identity to human zyxin (Fig. 2C) and 57% identity 
to chicken zyxin at the amino acid level. The complete nucleo­
tide sequences for the mouse cDNAs characterized in this study 
are available from the GenBankTM/EMBL Data Bank under 
accession numbers X99063 and Y07711.
D istribution  an d  Expression o f  H um an Zyxin m RNA—A 
Northern blot analysis of mRNA from 16 human tissues using 
the human zyxin cDNA coding region as probe revealed a single 
transcript of —2.2 kb in all tissues (Fig. 3A). Northern analysis 
revealed that human zyxin is ubiquitously expressed. A glyc- 
eraldehyde-3-phosphate dehydrogenase probe was used to as­
sess the quality of the RNA in each lane (data not shown). 
Because transcripts encoding glyceraldehyde-3-phosphate de­
hydrogenase are not expressed uniformly in different tissues 
(Spanakis, 1993), we quantitated the relative levels of zyxin 
expression by normalizing the PhosphorImager values to 
amounts (micrograms) of poly(A)+ RNA loaded in each lane. By 
this approach, we determined that the level of human zyxin 
mRNA is highest in the lung. Colon and blood were also rela­
tively rich in this mRNA, while expression was relatively low in
F ig . 4 . C h a r a c t e r i z a t i o n  o f  t h e  a n t i - z y x i n  a n t i b o d y .  A , s h o w n  is  
a  C o o m a s s ie  B lu e - s t a in e d  S D S - p o ly a c r y la m id e  g e l  s h o w in g  m o l e c u l a r  
m a s s  m a r k e r s  (lane 1; i n  k i l o d a l to n s )  a n d  p r o t e in s  o f  a  H E L  c e l l  l y s a t e  
(lane 2 ) .  B , p r o t e in s  f r o m  a  p a r a l l e l  g e l  w e r e  t r a n s f e r r e d  to  n i t r o c e l lu ­
lo s e  a n d  p r o b e d  w i t h  t h e  a n t i - z y x i n  a n t ib o d y  (lane 2 ' ) .  A  s in g le  p r o t e in  
w i t h  a n  a p p a r e n t  m o l e c u l a r  m a s s  o f  8 4  k D a  i s  d e t e c te d  b y  t h e  a n t i -  
z y x in  a n t ib o d y .
the pancreas (Fig. 3B ).
Association o f H um an Zyxin w ith  S ites o f Cell-Substratum  
A dhesion—To characterize further the relationship between 
the product of our cDNA clone and zyxin, we generated an 
anti-peptide antibody against the human protein and used this 
to examine the subcellular distribution of the protein by indi­
rect immunofluorescence. Because zyxin expression appears to 
be relatively high in blood cells (Fig. 3), we examined the 
expression and subcellular distribution of zyxin in human 
erythroleukemia (HEL) cells. By Western immunoblot analy­
sis, the antibody specifically recognizes a polypeptide that mi­
grates at 84 kDa in HEL cells (Fig. 4). The immunoreactive 
protein in human cells behaves as if it is slightly larger than 
avian zyxin, which migrates at an apparent molecular mass of 
82 kDa. This is consistent with the slightly greater size of the 
protein product in humans; chicken zyxin is 542 amino acids in 
length compared with 572 for the human protein. The high 
proline content of zyxin contributes to the reduced mobility 
observed on SDS-polyacrylamide gels (Sadler et al., 1992; 
Schmeichel and Beckerle, 1994).
The subcellular distribution of zyxin in HEL cells was eval­
uated by indirect immunofluorescence (Fig. 5). HEL cells grow 
in suspension, but can be induced to spread and form focal 
adhesions when plated on a fibronectin substratum and stim­
ulated with a tumor-promoting phorbol ester. Zyxin is diffusely 
distributed in suspension cells (Fig. 5A). When adhesion and 
spreading is stimulated, zyxin localizes to patches at the cell 
borders that are reminiscent of focal contacts (Fig. 5B ). Some 
nuclear staining is occasionally observed, but the extent of this 
staining varies in different preparations. No staining is de­
tected with preimmune serum (Fig. 5C).
To confirm that the staining observed in adherent cells co­
incides with the distribution of focal contacts, we examined the 
same cells by indirect immunofluorescence to localize zyxin and 
by interference reflection contrast microscopy to identify un­
equivocally the regions of close membrane-substratum contact. 
As can be seen in Fig. 5 (D and E ), zyxin accumulates precisely 
at regions of cell-substratum adhesion. The localization of the 
human protein to these specialized regions of the plasma mem­
brane provides further support for the suggestion that we have 
isolated the human homologue of zyxin.
Zyxin-related Sequences in the H um an Genome—When total 
human genomic DNA was digested with BamHI, Bglii, D rai, 
EcoRI, EcoRV, or H indIII and probed at high stringency with a 
human zyxin cDNA probe, a simple hybridization pattern was 
obtained (Fig. 6A). The hybridization pattern is characteristic 





























F ig . 5. A n t i b o d y  d i r e c t e d  a g a i n s t  t h e  z y x i n  p e p t i d e  s t a i n s  f o ­
c a l  c o n t a c t s  o f  a d h e r e n t  H E L  c e l l s .  T h e  lo c a l i z a t i o n  o f  z y x in  w a s  
e x a m in e d  b y  in d i r e c t  im m u n o f lu o r e s c e n c e .  A, s h o w n  a r e  n o n a d h e r e n t  
H E L  c e l ls  s t a i n e d  w i t h  a n t i - z y x i n  a n t ib o d y .  B, H E L  c e l ls  w e r e  s t i m u ­
l a t e d  to  a d h e r e  b y  e x p o s u r e  to  a  f ib r o n e c t in - c o a te d  c o v e rs l ip  i n  t h e  
p r e s e n c e  o f  t u m o r - p r o m o t i n g  p h o r b o l  e s t e r  a n d  w e r e  s t a i n e d  w i t h  t h e  
a n t i - z y x i n  a n t ib o d y .  T h e  c e l ls  a r e  b r ig h t ly  la b e le d  a t  t h e  c e ll  p e r i p h e r y ,  
w h e r e  n e w ly  fo rm e d  a d h e s i o n  p la q u e s  a r e  p r o m i n e n t .  O c c a s io n a l  n u ­
c l e a r  s t a i n i n g  i s  a l s o  o b s e r v e d ,  b u t  t h e  s ig n i f ic a n c e  o f  t h i s  l a b e l i n g  is  n o t  
c l e a r .  C, n o  s t a i n i n g  i s  o b s e r v e d  w i t h  p r e i m m u n e  s e r u m .  D, s h o w n  i s  a  
h i g h e r  m a g n i f i c a t i o n  v ie w  o f  a n  a d h e r e n t  H E L  c e ll  s t a i n e d  w i t h  t h e  
a n t i - z y x i n  a n t ib o d y .  N o te  t h e  p r o m i n e n t  s t a i n i n g  o f  s t r u c t u r e s  a t  t h e  
c e ll  p e r i p h e r y .  E, t h e  s a m e  c e l l  a s  i n  D i s  o b s e r v e d  b y  i n t e r f e r e n c e  
r e f l e c t i o n  c o n t r a s t  m ic ro s c o p y  to  v i s u a l iz e  t h e  a r e a s  o f  c lo s e s t  m e m -  
b r a n e - s u b s t a t u m  c o n ta c t ;  t h e s e  r e g io n s  a p p e a r  black a n d  c o r r e s p o n d  
p r e c i s e ly  to  t h e  a r e a s  o f  p r o m i n e n t  l a b e l i n g  w i t h  t h e  a n t i - z y x i n  a n t i ­
b o d y  o b s e r v e d  i n  D . Bars =  3 0  x m .
Searches of the GenBankTM/EMBL Data Bank revealed two 
other human proteins that bear a striking resemblance to zyxin 
(Fig. 6B). The human zyxin protein sequence is very similar to 
the sequence of a protein that is frequently fused to the 
HMGI-C transcription factor in human lipomas (Schoenmakers 
et al., 1995; Ashar et al., 1995). The LPP (lipoma-preferred 
partner) protein is closely related to zyxin in the LIM domain 
region and also exhibits a proline-rich N-terminal domain with 
proline-rich repeats similar to those found in human zyxin 
(Petit et al., 1996). in  addition to LPP, zyxin is related to a 
protein referred to as Trip6 (thyroid receptor-interacting pro­
tein), which was identified as a ligand-dependent binding part­
ner for the thyroid hormone receptor (Lee et al., 1995). The
F ig . 6 . Z y x i n - r e l a t e d  s e q u e n c e s  i n  h u m a n s .  A , a  S o u t h e r n  b lo t  
a n a ly s i s  o f  t h e  z y x in  g e n e .  E a c h  l a n e  c o n ta in e d  10  xg  o f  t o t a l  h u m a n  
g e n o m ic  D N A  d ig e s t e d  w i t h  B a m H I ,  B g l l l ,  E c o R I ,  E c o R V , H i n d l l l ,  o r  
D r a l .  T h e  b lo t  w a s  h y b r id i z e d  w i t h  32P - la b e le d  c D N A  c o r r e s p o n d in g  to  
t h e  r e g io n  e n c o d in g  t h e  L IM  d o m a in  s e q u e n c e s  o f  h u m a n  z y x in . T h e  
p o s i t i o n s  o f  t h e  D N A  s iz e  m a r k e r s  i n  k b  a r e  i n d i c a t e d  o n  t h e  le f t .  B ,  a  
s c h e m a t i c  r e p r e s e n t a t i o n  o f  t h e  z y x in  p r o t e i n  a n d  tw o  o t h e r  h u m a n  
s e q u e n c e s  t h a t  s h o w  s ig n i f i c a n t  s i m i l a r i t y  to  z y x in . T r ip 6  i s  a  th y r o id  
r e c e p t o r - i n t e r a c t i n g  p r o t e in ,  a n d  L P P  i s  a  l i p o m a - p r e f e r r e d  p a r t n e r  
t h a t  i s  f u s e d  to  t h e  D N A -b in d in g  d o m a in  o f  H M G I-C  i n  c o m m o n  b e n ig n  
m e s e n c h y m a l  tu m o r s .  T h e  a m in o  a c id  s e q u e n c e s  c o r r e s p o n d in g  to  t h e  
boxed r e g io n s  w e r e  c o m p a r e d  i n d i v id u a l ly  w i t h  t h e  s e q u e n c e  o f  h u m a n  
z y x in ,  a n d  t h e  r e l a t i o n s h i p  to  h u m a n  z y x in  ( p e r c e n t  a m in o  a c id  i d e n ­
t i t y )  i s  s h o w n  f o r  e a c h  a r e a  a n a ly z e d .  aa, a m in o  a c id s .
available Trip6 sequence information corresponds to the C 
terminus of the protein and specifies two complete and one 
partial LIM domain. Interestingly, the second and third LIM 
domains of both LPP and Trip6 independently exhibit 62 and 
65% amino acid sequence identities to the corresponding LIM 
domains of zyxin. LPP and Trip6 are more similar to each other 
than either is to zyxin, displaying 77% amino acid identity in 
LIM2 and 74% amino acid identity in LIM3.
Chromosomal M apping—Southern analysis and a PCR- 
based screen were employed to map the chromosomal location 
of the human zyxin gene. In our initial mapping studies, the 
human zyxin gene was assigned to chromosome 7 by discord­
ancy analysis using Southern blot hybridization of a zyxin 
cDNA probe to a human-rodent somatic cell hybrid panel (Ta­
ble I). The panel represents the complete population of human 
chromosomes with individual hybrids containing different 
chromosome complements (Boyle et al., 1992; Luerssen et al., 
1990). EcoRI-restricted DNA corresponding to each hybrid cell 
type in the panel was hybridized with a human zyxin cDNA 
probe (0.6 kb). Analysis of the correlation between the presence 
(cell lines 1-5, 7, 8 , 14, and 18) and absence (cell lines 6, 9-13, 
and 15-17) of the specific human signal (6.8 kb) and the human 
chromosome content shows that zyxin is encoded by a single 
locus in the human genome that is present on chromosome 7 
(Table I). Hybridization to DNA isolated from the monochro- 
mosomal chromosome 7 human-mouse cell hybrid 5387-3 
















31476 M o lecu lar C h a ra c teriza tion  o f  H u m a n  Z y x in
T a b l e  I
Segregation of human zyxin in human-rodent somatic cell hybrids 
+  , c h ro m o s o m e  p r e s e n t ;  —, c h ro m o s o m e  a b s e n t ;  o, c h ro m o s o m e  f r a g m e n t ;  ± ,  c h ro m o s o m e  o r  c h ro m o s o m e  f r a g m e n t ( s )  p r e s e n t  o n ly  i n  a  m i n o r i t y  
o f  c e l ls  (< 3 0 % ) ;  (o a n d  ±  d a t a  w e r e  n o t  i n c lu d e d  i n  t h e  c o r r e l a t i o n  a n a ly s i s ) .  C e l l  l i n e s  w e r e  a s  fo llo w s : 1, h u m a n  D N A ; 2 - 1 0  a n d  1 4 - 1 6 ,  
h u m a n - m o u s e  c e ll  h y b r id  D N A ; 11  a n d  1 2 , h u m a n - h a m s t e r  c e ll  h y b r id  D N A ; 1 3 , C h in e s e  h a m s t e r  D N A ; 17 , m o u s e  D N A ; a n d  1 8 , m o n o c h ro m o -  
s o m a l  c h ro m o s o m e  7 h u m a n - m o u s e  s o m a t ic  c e l l  h y b r id  D N A .
Cell line
H u m an  chrom osom es
iyxin 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X
+ + + + + + + + + + + + + + + + + + + + + + + +
+ — ± + + — o + + — — + — ± — + + + + + — + + +
+ ± — + + + ± + — o — o + — o — o o + — — + — o
+ + — + — + + + ± + — o ± — + o — — + — — — ± o
+ ± o + + + + + ± — + + ± — + + + + + + + + + o
— + — o + + — — + — + — o ± — — o — — + — + — o
+ — — o + + + + — — + — + + + — + — — o + + — o
+ — — ± + — — + + — o — — + + + — — ± — — — + o
— — — o — + o o — — — — — o — — — — — — — + — +
— — + o o — + — — — — o — + + — — o + — — + — —
— ± — ± + — + — + — + o + — + — — + — — — + + +
— + — + + — — — ± — + o + — + — — + — — — + + +
+ — — + + — — + — — — + — — — + o — + o o + + o
— — o — — — — — — — — + — + o + o












1. G M  3 1 0 4
2. B 8 2 /M S 2 , c l .1 a - 1 4 - 1
3. R a g /A N L Y , c l.1
4 . R a g /P I ,  c l .7 - 2
5. R a g /P I ,  c l .5 - 1 5
6. R a g /G M  1 9 4 , c l.7
7 . R a g /G M  1 9 4 , c l .5 - 5
8 . R a g /G O , c l .4
9 . R a g /S U , c l .3 - 1 - 2 - 3
10 . A 9 /S U , c l .1 - 2
11 . V 7 9 /L y , c l .3 - 2
12 . V 7 9 /L y , c l .3 - 3
13 . P 3
14 . A 9 /G M  8 9 , c l.9 c -7
15. A 9 /M S  5 8 , c l .2 b
16. R a g /G M 7 9 , c l .8 -1 3 - 3
17. R a g
18. 5 3 8 7 - 3 ,  c l .1 0 + +
N o . o f  c o n c o rd a n t ( + / + ) 1 0 5 6 4 3 8 2 1 2 3 2 2 4 4 3 2 5 2 2 5 4 1 1
h y b r id s
( —/ —) 3 5 2 2 5 4 6 4 6 4 2 4 3 2 6 6 3 6 6 7 2 4 1 5
N o . o f  d i s c o r d a n t ( + / —) 5 6 1 2 4 3 0 4 6 5 3 4 5 3 3 3 5 2 4 5 3 3 1 7
h y b r id s
( —/ + ) 2 1 1 4 2 2 0 2 1 3 2 2 2 4 1 0 3 1 1 0 5 2 3 2
% d is c o r d a n c y 6 4 58 22 4 3 4 0 42 0 50 50 57 5 0 50 58 5 4 2 9 25 61 21 3 8 3 6 53 3 8 67 6 0
We have further defined the location of the gene within 
human chromosome 7 using PCR amplification of DNA from 
well characterized human-rodent somatic cell hybrids that con­
tain fragments of this chromosome (Fig. 7). All the hybrid cell 
lines employed have been described previously (Croce and Ko- 
prowski, 1974; Rommens et al., 1988; Vortkamp et al., 1991). 
PCR amplification of zyxin sequences using zyxin-specific 
primers results in a 270-bp product. As can be seen in Fig. 7, 
sequences present on the long arm of human chromosome 7 are 
required for amplification driven by zyxin-specific primers. The 
lack of amplification using 194 Rag 6-13 genomic DNA as 
template localizes the gene encoding zyxin to chromosomal 
region 7q32-q36. No amplification occurs when murine DNA is 
used as template (Fig. 7, Rag DNA).
D IS C U S S IO N
In this paper, we have reported the molecular characteriza­
tion of human zyxin. Evidence that we have isolated cDNAs 
that encode the human homologue of zyxin includes the sub­
stantial similarity in domain organization and sequence as well 
as the common subcellular distributions of the protein when 
compared with avian zyxin. Moreover, Southern analysis has 
revealed that the human sequences we have characterized are 
the sequences that are most closely related to the coding region 
of avian zyxin. Zyxin is widely expressed in human tissues, but 
is most prominent in blood cells and in tissues that are rich in 
smooth muscle and endothelial cells, such as lung and colon.
The amino acid sequence of zyxin suggests certain functions 
for the protein. Chicken zyxin, as well as the human and mouse 
forms of zyxin characterized here, displays substantial proline- 
rich repeats as well as three copies of the LIM domain. Proline- 
rich regions of proteins can serve as molecular spacers (Stryer, 
1978; Stryer and Haugland, 1967) or as surfaces for interaction 
with specific ligands such as proteins that exhibit SH3 domains 
(Ren et al., 1993). SH3 domains were first defined in the human 
proto-oncogene product Src and have now been identified in a 
large number of proteins, many of which participate in signal
transduction. In aqueous solution, proline arrays typically 
adopt an extended conformation called a polyproline II helix, 
which is well suited for high affinity binding since it displays 
very limited mobility in solution (Williamson, 1994). interest­
ingly, proteins that are rich in proline residues are often rich in 
glutamines as well. Like prolines, glutamines are predicted to 
prefer a polyproline II helical secondary structure (Adzhubei 
and Sternberg, 1993). in  this regard, it is intriguing that hu­
man zyxin displays a 37-amino acid sequence (not found in 
avian zyxin) that is 50% proline and glutamine.
The proline-rich regions of zyxin derived from human, mu­
rine, and avian sources also exhibit a number of specific se­
quences that are very similar to proline-rich repeats ((D/E)FP- 
PPP) found in the ActA protein of the intracellular pathogen L. 
monocytogenes (reviewed by Lasa and Cossart (1996)). The 
ActA protein is a bacterial surface component that is critical for 
transmission of the pathogen (Kocks e ta l ., 1992; Domann e ta l.,  
1992). In a eukaryotic cell that is infected with L isteria , the 
cytoplasmic bacteria harness host cell machinery to assemble 
actin-rich comet tails that allow the bacteria to move within the 
host cytoplasm and to infect adjacent cells (reviewed by Tilney 
and Tilney (1993)). The L isteria  ActA protein is required for the 
ability of a bacterium to nucleate and polymerize the surface- 
bound actin that is necessary for its effective transmission to 
uninfected cells (Kocks et al., 1992; Domann et al., 1992). Anal­
ysis of the ActA protein has revealed that proline-rich repeats 
found in the central region of the protein, although not required 
for the initial polymerization of actin, stimulate the assembly 
of filamentous actin in association with the bacterial surface 
(Southwick and Purich, 1994; Pistor et al., 1994, 1995; Lasa et 
al., 1995). The similarity of zyxin sequences to the bioactive 
proline-rich repeats in ActA raises the possibility that zyxin 
may be a cellular analogue of ActA. if  this were the case, zyxin, 
like ActA, would be expected to play a role in the spatial control 
of actin assembly within cells. This suggestion gains some 






























F ig . 7 . R e g i o n a l  m a p p i n g  o f  t h e  h u ­
m a n  z y x i n  g e n e .  Top, s c h e m a t i c  r e p r e ­
s e n t a t i o n  o f  t h e  h u m a n  c h ro m o s o m e  7 
c o n t e n t  o f  e a c h  s o m a t ic  c e ll  h y b r id  a n d  o f  
t h e  c o n t r o l  t e m p la t e .  H y b r id  5 3 8 7 -3 , 
c l .1 0 , c o n t a in s  o n ly  c h ro m o s o m e  7 a s  h u ­
m a n  m a t e r i a l .  T h e  bar i n d i c a t e s  t h e  c h r o ­
m o s o m a l  r e g i o n  ( 7 q 3 2 - q 3 6 )  c o n t a in i n g  
t h e  h u m a n  z y x in  g e n e  (ZYX). Bottom, t h e  
e t h i d i u m  b r o m i d e - s ta i n e d  a g a r o s e  g e l  o f  
t h e  P C R  p r o d u c t s  s h o w s  t h e  p r e s e n c e  o r  
a b s e n c e  o f  t h e  2 7 0 -b p  h u m a n  z y x in - s p e -  
c if ic  f r a g m e n t  i n  t h e  g e n o m ic  t e m p la t e  
D N A s  in d i c a t e d  b e lo w  t h e  c o r r e s p o n d in g  
l a n e s .  F o r  s iz e  d e t e r m i n a t io n ,  t h e  D N A  
m o l e c u l a r  w e ig h t  m a r k e r  s y s t e m  V I I I  
f r o m  B o e h r i n g e r  M a n n h e i m  w a s  u s e d .
tein called VASP (Reinhard et al., 1995b). VASP, a vasodilator- 
stimulated phosphoprotein that was originally characterized in 
human platelets, is a profilin-binding partner that is itself 
implicated in actin assembly (Halbrugge and Walter, 1989; 
Haffner et al., 1995; Reinhard et al., 1995a, 1995b).
The three LIM domains present in human zyxin are closely 
related to those found in avian zyxin (Sadler et al., 1992). 
Interestingly, it was recently discovered that sequences related 
to the LIM region of zyxin are encoded by chimeric transcripts 
associated with lipomas, a common mesenchymal neoplasm in 
humans (Ashar et al., 1995; Schoenmakers et al., 1995; Petit et 
al. , 1996). A major subclass of lipomas are characterized by 
chromosomal translocations involving chromosome 12  that re­
sult in rearrangements in the gene encoding HMGI-C, a high 
mobility group protein that binds to DNA and influences tran­
scription by modulating the local conformation of the nucleic 
acid (Ashar et al., 1995; Schoenmakers et al., 1995; Thanos and 
Maniatis, 1992; Du et al., 1993; Wolffe, 1994). The LPP  gene on 
chromosome 3 is a preferred translocation partner in these 
lipomas (Ashar et al., 1995; Schoenmakers et al., 1995). The 
LPP protein is similar to zyxin in both sequence and overall 
molecular architecture (Fig. 6B ) and may represent another 
zyxin family member. In the HMGI-C/LPP chimeric proteins 
that characterize the tumor cells, LIM domains derived from 
LPP are linked to the DNA-binding domain of HMGI-C. Since 
the LIM domain mediates specific protein-protein interactions 
(Schmeichel and Beckerle, 1994; Wu and Gill, 1994; Feuerstein 
et al. , 1994), it seems likely that LIM-dependent recruitment of 
protein factors adversely affects transcriptional regulation by 
HMGI-C and thus contributes to tumorigenesis.
The LIM region of zyxin is also very similar to a sequence in 
the Trip6 protein that was identified based on its ability to 
interact with the thyroid hormone receptor in a ligand-depend­
ent fashion (Lee et al., 1995). The physiological relevance of 
this relationship is not understood at present. Although Trip6, 
LPP, and zyxin are clearly encoded by distinct human genes, 
the LIM regions contained in these proteins are closely related 
in sequence. Since LIM domains display specific protein bind­
ing preferences (Schmeichel and Beckerle, 1994), it is possible 
that these closely related LIM domains may exhibit common 
binding partners and thus may have related functions.
Zyxin has been implicated in a number of important signal­
ing pathways that regulate cell differentiation, proliferation, 
and morphology. Because of the domain structure of zyxin, we 
have postulated that zyxin may function by mediating the 
assembly of multimeric protein complexes (Schmeichel and 
Beckerle, 1994). Each LIM domain of zyxin may be able to 
associate with specific protein partners, and the proline region 
clearly has the capacity to interact with a number of proteins 
(Sadler et al., 1992; Reinhard et al., 1995b; Crawford et al., 
1992; Hobert et al., 1996). Based on the recent identification of 
zyxin-binding partners, it appears likely that zyxin may par­
ticipate in a variety of processes within cells. For example, 
zyxin has been shown to interact with members of the cysteine- 
rich protein family that are required for muscle differentiation 
(Arber et al., 1994). in addition, zyxin’s ability to associate with 
Vav, a human proto-oncogene product that is required for sig­
naling and proliferation of T- and B-cells, suggests a role for 
zyxin in Vav-dependent processes (Hobert et al., 1996). As 




























that zyxin and its binding partners may participate in the 
regulated, spatially localized assembly of filamentous actin by 
virtue of its similarity to the L isteria  protein ActA and its 
ability to interact with the profilin-binding proteins (VASP).
Most work on zyxin has focused on functions related to its 
protein binding activity. However, structural features of the 
LiM domain (Perez-Alvarado et al., 1994) suggest that these 
zinc fingers may also have the capacity to associate with nu­
cleic acid. Of particular interest in this regard are recent ex­
periments in which zyxin sequences were identified as a bind­
ing partner for the thrombomodulin gene promoter.3 Thus, 
zyxin may be able to function in both the nucleus and the 
cytoplasm. Over the past few years, zyxin has emerged as an 
interesting constituent of the focal contact that may play a role 
in signal transduction at those specialized regions of the 
plasma membrane. The availability of molecular probes for 
zyxin should enable higher resolution analysis of zyxin’s phys­
iological function.
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